FDA Drug Recalls

Recalls / Class II

Class IID-0371-2024

Product

Rocuronium Bromide Injection, Preservative Free, 10 mg / mL, Multiple-Dose Vial 10 mL, Rx only, Mfg: Auromedics Pharma LLC, NDC 55150-226-10

Brand name
Rocuronium Bromide
Generic name
Rocuronium Bromide
Active ingredient
Rocuronium Bromide
Route
Intravenous
NDCs
55150-225, 55150-226
FDA application
ANDA206206
Affected lot / code info
1064081

Why it was recalled

cGMP Deviations: Products were stored outside the drug label specifications.

Recalling firm

Firm
Mckesson Medical-Surgical Inc. Corporate Office
Manufacturer
Eugia US LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
9954 Maryland Drive, Deep Run Iii Ste. 4000, Richmond, Virginia 23233

Distribution

Quantity
70 vials
Distribution pattern
Product was distributed to three direct accounts in NM, AZ and UT.

Timeline

Recall initiated
2024-02-07
FDA classified
2024-03-08
Posted by FDA
2024-03-20
Terminated
2024-08-14
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0371-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Rocuronium Bromide · FDA Drug Recalls